Search research articles
Contact Us
Filters
Showing results (1-10 of 17) with videos related to
Page
of 2
Sort By:
Memoires De L'Academie Royale De Medecine De Belgique
|
January 1, 1974
[Study of the daunomycin-DNA complex]
D Deprez-De Campeneere
European Journal of Cancer
|
August 1, 1980
DNA--anthracycline complexes. I. Toxicity in mice and chemotherapeutic activity against L1210 leukemia of daunorubicin--DNA and adriamycin--DNA
D Deprez-de Campeneere, A Trouet
Cancer Chemotherapy and Pharmacology
|
January 1, 1979
Daunorubicin-DNA and doxorubicin-DNA. A review of experimental and clinical data
A Trouet, D Deprez-De Campeneere
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Accumulation and metabolism of new anthracycline derivatives in the heart after IV injection into mice
D Deprez-de Campeneere, R Baurain, A Trouet
Analytical Biochemistry
|
April 1, 1979
Rapid determination of doxorubicin and its fluorescent metabolites by high pressure liquid chromatography
R Baurain, D Deprez-De Campeneere, A Trouet
Cancer Chemotherapy and Pharmacology
|
January 1, 1979
Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: plasma levels in DBA2 mice
R Baurain, D Deprez-De Campeneere, A Trouet
Cancer Treatment Reports
|
May 1, 1979
Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin
D Deprez-de Campeneere, R Baurain, A Trouet
Cancer Chemotherapy and Pharmacology
|
January 1, 1979
Distribution and metabolism of rubidazone and daunorubicin in mice
R Baurain, D Deprez-De Campeneere, A Trouet
Nature: New Biology
|
September 27, 1972
Chemotherapy through lysosomes with a DNA-daunorubicin complex
A Trouet, D Deprez-de Campeneere, C De Duve
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1982
A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies
A Trouet, M Masquelier, R Baurain, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 17) with videos related to
Sort By:
Page
of 2
Memoires De L'Academie Royale De Medecine De Belgique
|
January 1, 1974
[Study of the daunomycin-DNA complex]
D Deprez-De Campeneere
European Journal of Cancer
|
August 1, 1980
DNA--anthracycline complexes. I. Toxicity in mice and chemotherapeutic activity against L1210 leukemia of daunorubicin--DNA and adriamycin--DNA
D Deprez-de Campeneere, A Trouet
Cancer Chemotherapy and Pharmacology
|
January 1, 1979
Daunorubicin-DNA and doxorubicin-DNA. A review of experimental and clinical data
A Trouet, D Deprez-De Campeneere
Cancer Chemotherapy and Pharmacology
|
January 1, 1982
Accumulation and metabolism of new anthracycline derivatives in the heart after IV injection into mice
D Deprez-de Campeneere, R Baurain, A Trouet
Analytical Biochemistry
|
April 1, 1979
Rapid determination of doxorubicin and its fluorescent metabolites by high pressure liquid chromatography
R Baurain, D Deprez-De Campeneere, A Trouet
Cancer Chemotherapy and Pharmacology
|
January 1, 1979
Determination of daunorubicin, doxorubicin and their fluorescent metabolites by high-pressure liquid chromatography: plasma levels in DBA2 mice
R Baurain, D Deprez-De Campeneere, A Trouet
Cancer Treatment Reports
|
May 1, 1979
Pharmacokinetic, toxicologic, and chemotherapeutic properties of detorubicin in mice: a comparative study with daunorubicin and adriamycin
D Deprez-de Campeneere, R Baurain, A Trouet
Cancer Chemotherapy and Pharmacology
|
January 1, 1979
Distribution and metabolism of rubidazone and daunorubicin in mice
R Baurain, D Deprez-De Campeneere, A Trouet
Nature: New Biology
|
September 27, 1972
Chemotherapy through lysosomes with a DNA-daunorubicin complex
A Trouet, D Deprez-de Campeneere, C De Duve
Proceedings of the National Academy of Sciences of the United States of America
|
January 1, 1982
A covalent linkage between daunorubicin and proteins that is stable in serum and reversible by lysosomal hydrolases, as required for a lysosomotropic drug-carrier conjugate: in vitro and in vivo studies
A Trouet, M Masquelier, R Baurain, et al.
Page
of 2